Results 91 to 100 of about 691,423 (211)

The role of meibomian gland dysfunction on the development of dry eye disease in patients with facial nerve palsy

open access: yes, 2022
Purpose: To investigate whether meibomian gland dysfunction is the cause of dry eye in facial nerve palsy and to identify the possible relationship between the grades and durations of facial nerve palsy and meibomian gland dysfunction.
Meryem Altın Ekın (12684270)   +3 more
core   +1 more source

Meibomian gland dysfunction. III. Meibomian gland lipids.

open access: yesInvestigative ophthalmology & visual science, 1989
The lipid components of meibomian gland excreta were evaluated in rabbits after they received 2% topical epinephrine dropped into their eyes daily for a period of 6 months to a year to induce meibomian gland dysfunction (MGD). Changes were compared to excreta obtained from seven age-matched, untreated control rabbits.
N, Nicolaides   +3 more
openaire   +1 more source

Pathogens in the Meibomian gland and conjunctival sac: microbiome of normal subjects and patients with Meibomian gland dysfunction

open access: yes, 2018
Xiaodan Jiang,1,2,* Aihua Deng,3,* Jiarui Yang,1,2,* Hua Bai,3 Zhao Yang,3 Jie Wu,3 Huibin Lv,1,2 Xuemin Li,1,2 Tingyi Wen3,4 1Department of Ophthalmology, Peking University Third Hospital, Beijing 100191, China; 2Beijing Key Laboratory of Restoration of
Wu J   +8 more
core  

Impact of pterygium on the ocular surface and meibomian glands.

open access: yesPLoS ONE, 2019
PurposeTo analyze how ocular surface parameters correlate to presence of pterygium and investigate the possible impact of pterygia on tear film findings and meibomian glands findings.MethodsWe investigated objective parameters of the ocular surface such ...
Ana Claudia Viana Wanzeler   +5 more
doaj   +1 more source

Preliminary investigation on the establishment of a new meibomian gland obstruction model and gene expression

open access: yesScientific Reports
Meibomian gland dysfunction is a chronic ocular surface disease with a complex pathogenesis, whose main clinical manifestations are meibomian gland obstruction or/and lipid abnormalities. To explore the mechanism of MGD due to meibomian gland obstruction
Ming Sun   +8 more
doaj   +1 more source

Efficacy of intra-meibomian gland injection of the anti-VEGF agent bevacizumab for the treatment of meibomian gland dysfunction with lid-margin vascularity

open access: yes, 2018
Xiaodan Jiang,* Yuexin Wang,* Huibin Lv, Yan Liu, Mingzhou Zhang, Xuemin Li Department of Ophthalmology, Peking University Third Hospital, Beijing, China *These authors contributed equally to this work Purpose: To investigate the efficacy of a novel ...
Liu Y   +5 more
core  

Meibomian Gland Dysfunction in Patients Receiving Long-Term Glaucoma Medications

open access: yes, 2016
Purpose: The purpose of this study was to evaluate the impact of meibomian gland dysfunction (MGD) on the ocular surface of patients with medically treated ...
Mocan, Mehmet C.   +4 more
core   +1 more source

Meibomian Gland Dysfunction: What Have Animal Models Taught Us?

open access: yes, 2020
Studies have estimated that currently 344 million people worldwide and 16.4 million adults in the US have some form of dry eye disease (DED). It is believed that approximately 70% of DED cases are due to some form of evaporative dry eye, for which ...
Isabel Y. Moreno   +3 more
core   +1 more source

Association of Meibomian Gland Orifice Changes with Intense Pulsed Light Treatment Response in Meibomian Gland Dysfunction

open access: yes
Purpose: To investigate epidemiological factors and clinical manifestations associated with longitudinal treatment response to intense pulsed light in patients with meibomian gland dysfunction (MGD).
Ikhyun Jun   +4 more
core   +1 more source

Combined use of 0.1% fluorometholone and meibomian gland expression improves symptoms of moderate and severe dry eye disease, even in patients with systemic immune disease

open access: yesBiotechnology & Biotechnological Equipment, 2019
This study prospectively evaluated the effect of 0.1% fluorometholone (FML) combined with meibomian gland expression (MGX) on dry eye disease (DED) and meibomian gland dysfunction (MGD).The study included 48 patients (96 eyes) with moderate to severe DED.
Xuming Guo   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy